1 / 12

Neuralgia Treatment Market Size, Share, Growth, Forecast To 2027

The neuralgia treatment market is expected to witness significant growth owing to the increasing incidences of diabetes and trigeminal neuralgia. Furthermore, multiple sclerosis is also one of factors which can cause neuralgia. Multiple sclerosis decreases the body immunity owing to the neurodegenerative condition which affects the myelin sheath that can cause neuralgia. This is likely to drive market demand over the forecast period.

priyanka1988
Télécharger la présentation

Neuralgia Treatment Market Size, Share, Growth, Forecast To 2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Neuralgia Treatment Market Market Size Worth $2.83 Billion By 2027 | CAGR: 6.1%

  2. Neuralgia Treatment Market Size Worth $2.83 Billion By 2027 “According to Polaris Market Research report, Neuralgia Treatment market is witnessing major innovations & transformations and is anticipated to reach $2.83 Billion By 2027, registering a CAGR of 6.1% during the forecast period 2020 to 2027.” The global Neuralgia Treatment market report sheds light on the key dynamics of the global market, analyzing the data on a historical basis and forecasted data till the year 2027. The market analysis covered in the report includes data in terms of value $2.83 Billion By 2027. The market overview section of the report covers the global industry overview, microeconomic and macroeconomic outlook, and forecasted factors. The market dynamics section of this report includes major drivers, restraints, trends, and opportunities emerging in the market. Neuralgia Treatment Market Report Scope: The global Neuralgia Treatment market is segmented based on product/service type, end-use, and region. The motive of the research report is to define market dynamics of different countries & segments in the recent time and to forecast the values for the coming years. The report is specifically designed to incorporate quantitative and qualitative aspects of the market within each country and region involved in the study. The report caters the extensive information regarding the driving factors & hurdles that will define the future outlook for the market. Additionally, the report also incorporates prevailing and emerging opportunities for stakeholders to invest along with the in-depth detailed analysis of product/services offerings of prominent players shaping the overall development of the market. - 2 -

  3. Neuralgia Treatment Market Size Worth $2.83 Billion By 2027 By Treatment By End-Use By Region •Drug Based •Hospitals & Clinics •Ambulatory Surgery Centers •Others •North America (U.S., Canada) oAnticonvulsant Medicines oTricyclic Antidepressants •Surgeries oBalloon Compression •Glycerol Injection oRadiofrequency Thermal Lesioning oStereotactic Radiosurgery oMicrovascular Decompression •Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) •Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) •Latin America (Brazil, Mexico, Argentina) •Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa) COVID-19 Impact Analysis for Neuralgia Treatment Market COVID-19 is an ongoing public health emergency that has impacted almost all industries globally, and its long- term effects are expected to influence the target industry growth over the forecast period. Our ongoing research features the COVID-19 impact analysis section as a key part of the report to uncover the major issues and potential paths forward. In this report, the insights provided in terms of changes in consumer behavior and purchasing patterns, dynamics of current market forces, re-routing of the supply chain, and the interventions of governments. The latest study incorporates analysis, estimations, insights, and forecasts, considering the COVID-19 impact on the market. Browse Detailed Research Report On Neuralgia Treatment Market Analysis: https://www.polarismarketresearch.com/industry-analysis/neuralgia-treatment-market Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic impacting the the Neuralgia Treatment market in different regions and how leading players are forming strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities Regional Outlook Among regional markets, the region emerged as the promising regional market with its higher revenue share contribution. The growth in this regional market is primarily attributed to the ongoing technological - 3 -

  4. Neuralgia Treatment Market Size Worth $2.83 Billion By 2027 advancements in the industry, increasing economic stability, huge government investments, and growing awareness related to the benefits of the product/service. Competitive Landscape The report offers a complete industry analysis while featuring the competitive landscape that includes company financials, product portfolios, major breakthroughs, and upcoming projects. The report includes a detailed view of the global market, along with changing scenarios, trends, regional segmentation, regional landscape, major investments, and details of historical, present, and projected revenues. According to Polaris Market Research, the key players with a noteworthy dominance in the Neuralgia Treatment market include Allergan Plc, GlaxoSmithKline Plc., Biogen, Inc., Abbott Laboratories, PixarBio Corporation, Merz Pharma GmbH, Trigemina Inc., Pfizer Inc., Novartis, Lupin, and others. Request for sample: https://www.polarismarketresearch.com/industry-analysis/neuralgia-treatment-market/request-for- sample Table of Contents 1.Introduction 1.1.Report Description 1.1.1.Objectives of the Study 1.1.2.Market Scope 1.1.3.Assumptions 1.2.Stakeholders 2.Executive Summary 2.1.Market Highlights 3.Research Methodology 3.1.Overview 3.1.1.Data Mining 3.2.Data Sources 3.2.1.Primary Sources 3.2.2.Secondary Sources 4.Neuralgia Treatment Market Insights 4.1.Neuralgia Treatment – Industry snapshot - 4 -

  5. Neuralgia Treatment Market Size Worth $2.83 Billion By 2027 4.2.Neuralgia Treatment Market Dynamics 4.2.1.Drivers and Opportunities 4.2.1.1. High incidence rate of Neuralgia 4.2.1.2. Sports injuries causing neuro-degenrative disorders 4.2.2.Restraints and Challenges 4.2.2.1. High cost of treatment 4.3.Porter’s Five Forces Analysis 4.3.1.Bargaining Power of Suppliers (Moderate) 4.3.2.Threats of New Entrants: (Low) 4.3.3.Bargaining Power of Buyers (Moderate) 4.3.4.Threat of Substitute (Moderate) 4.3.5.Rivalry among existing firms (High) 4.4.PESTLE Analysis 4.5.Neuralgia Treatment Market Industry trends 5.Neuralgia Treatment Market Assessment by Treatment 5.1.Key Findings 5.2.Introduction 5.2.1.Global Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 5.3.Drug Based 5.3.1.Global Neuralgia Treatment Market, by Drug Based, by Region, 2016 – 2027 (USD Million) 5.3.2.Anticonvulsant Medicines 5.3.2.1. Anticonvulsant Medicines Market, by Region, 2016 – 2027 (USD Million) 5.3.2.2. Carbamazepine 5.3.2.2.1. Carbamazepine Market, by Region, 2016 – 2027 (USD Million) 5.3.2.3. Oxcarbazepine 5.3.2.3.1. Oxcarbazepine Market, by Region, 2016 – 2027 (USD Million) 5.3.2.4. Topiramate 5.3.2.4.1. Topiramate Market, by Region, 2016 – 2027 (USD Million) 5.3.2.5. Gabapentin 5.3.2.5.1. Gabapentin Market, by Region, 2016 – 2027 (USD Million) 5.3.2.6. Pregabalin 5.3.2.6.1. Pregabalin Market, by Region, 2016 – 2027 (USD Million) 5.3.2.7. Clonazepam 5.3.2.7.1. Clonazepam Market, by Region, 2016 – 2027 (USD Million) 5.3.2.8. Phenytoin 5.3.2.8.1. Phenytoin Market, by Region, 2016 – 2027 (USD Million) - 5 -

  6. Neuralgia Treatment Market Size Worth $2.83 Billion By 2027 5.3.2.9. Lamotrigine 5.3.2.9.1. 5.3.2.10.Valproic Acid 5.3.2.10.1. 5.3.3.Tricyclic Antidepressants 5.3.3.1. Tricyclic Antidepressants Market, by Region, 2016 – 2027 (USD Million) 5.3.3.2. Amitriptyline 5.3.3.2.1. Amitriptyline Market, by Region, 2016 – 2027 (USD Million) 5.3.3.3. Nortriptyline 5.3.3.3.1. Nortriptyline Market, by Region, 2016 – 2027 (USD Million) 5.4.Surgery 5.4.1.Global Neuralgia Treatment Market, by Surgery, by Region, 2016 – 2027 (USD Million) 5.4.2.Balloon Compression 5.4.2.1. Balloon Compression Market, by Region, 2016 – 2027 (USD Million) 5.4.3.Glycerol Injection 5.4.3.1. Glycerol Injection Market, by Region, 2016 – 2027 (USD Million) 5.4.4.Radiofrequency Thermal Lesioning 5.4.4.1. Radiofrequency Thermal Lesioning Market, by Region, 2016 – 2027 (USD Million) 5.4.5.Stereotactic Radiosurgery 5.4.5.1. Stereotactic Radiosurgery Market, by Region, 2016 – 2027 (USD Million) 5.4.6.Microvascular Decompression 5.4.6.1. Microvascular Decompression Market, by Region, 2016 – 2027 (USD Million) 6.Global Neuralgia Treatment Market, by End Use 6.1.Key Findings 6.2.Introduction 6.2.1.Global Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 6.3.Hospital & Clinics 6.3.1.Global Neuralgia Treatment Market, by Hospital & Clinics, By Region, 2016 – 2027 (USD Million) 6.4.Ambulatory Surgery Centers 6.4.1.Global Neuralgia Treatment Market, by Ambulatory Surgery Centers, by Region, 2016 – 2027 (USD Million) 6.5.Others Lamotrigine Market, by Region, 2016 – 2027 (USD Million) Valproic Acid Market, by Region, 2016 – 2027 (USD Million) - 6 -

  7. Neuralgia Treatment Market Size Worth $2.83 Billion By 2027 6.5.1.Global Neuralgia Treatment Market, by Others, by Region, 2016 – 2027 (USD Million) 7.Neuralgia Treatment Market Assessment by Geography 7.1.Key findings 7.2.Introduction 7.2.1.Neuralgia Treatment Market Assessment, By Geography, 2016 – 2027 (USD Million) 7.3.Neuralgia Treatment Market – North America 7.3.1.North America: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.3.2.North America: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.3.3.Neuralgia Treatment Market – U.S. 7.3.3.1. U.S.: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.3.3.2. U.S.: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.3.4.Neuralgia Treatment Market – Canada 7.3.4.1. Canada: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.3.4.2. Canada.: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.4.Neuralgia Treatment Market – Europe 7.4.1.Europe: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.4.2.Europe: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.4.3.Neuralgia Treatment Market – UK 7.4.3.1. UK: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.4.3.2. UK: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.4.4.Neuralgia Treatment Market – France 7.4.4.1. France: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.4.4.2. France: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.4.5.Neuralgia Treatment Market – Germany 7.4.5.1. Germany: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.4.5.2. Germany: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.4.6.Neuralgia Treatment Market – Italy 7.4.6.1. Italy: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) - 7 -

  8. Neuralgia Treatment Market Size Worth $2.83 Billion By 2027 7.4.6.2. 7.4.7.Neuralgia Treatment Market – Spain 7.4.7.1. Spain: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.4.7.2. Spain: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.4.8.Neuralgia Treatment Market – Netherlands 7.4.8.1. Netherlands: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.4.8.2. Netherlands: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.4.9.Neuralgia Treatment Market – Austria 7.4.9.1. Austria: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.4.9.2. Austria: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.5.Neuralgia Treatment Market – Asia-Pacific 7.5.1.Asia Pacific: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.5.2.Asia Pacific: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.5.3.Neuralgia Treatment Market – China 7.5.3.1. China: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.5.3.2. China: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.5.4.Neuralgia Treatment Market – India 7.5.4.1. India: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.5.4.2. India.: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.5.5.Neuralgia Treatment Market – Malaysia 7.5.5.1. Malaysia: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.5.5.2. Malaysia: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.5.6.Neuralgia Treatment Market – Japan 7.5.6.1. Japan: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.5.6.2. Japan: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.5.7.Neuralgia Treatment Market – Indonesia Italy: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) - 8 -

  9. Neuralgia Treatment Market Size Worth $2.83 Billion By 2027 7.5.7.1. Indonesia: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.5.7.2. Indonesia: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.5.8.Neuralgia Treatment Market – South Korea 7.5.8.1. South Korea: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.5.8.2. South Korea.: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.6.Neuralgia Treatment Market – Middle East & Africa 7.6.1.Middle East & Africa: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.6.2.Middle East & Africa.: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.6.3.Neuralgia Treatment Market – Saudi Arabia 7.6.3.1. Saudi Arabia: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.6.3.2. Saudi Arabia.: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.6.4.Neuralgia Treatment Market – UAE 7.6.4.1. UAE: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.6.4.2. UAE: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.6.5.Neuralgia Treatment Market – Israel 7.6.5.1. Israel: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.6.5.2. Israel: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.6.6.Neuralgia Treatment Market – South Africa 7.6.6.1. South Africa: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.6.6.2. South Africa: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.7.Neuralgia Treatment Market – Latin America 7.7.1.Latin America: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.7.2.Latin America: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.7.3.Neuralgia Treatment Market – Mexico 7.7.3.1. Mexico: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) - 9 -

  10. Neuralgia Treatment Market Size Worth $2.83 Billion By 2027 7.7.3.2. Mexico.: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.7.4.Neuralgia Treatment Market – Brazil 7.7.4.1. Brazil: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.7.4.2. Brazil.: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 7.7.5.Neuralgia Treatment Market – Argentina 7.7.5.1. Argentina: Neuralgia Treatment Market, By Treatment, 2016 – 2027 (USD Million) 7.7.5.2. Argentina.: Neuralgia Treatment Market, By End Use, 2016 – 2027 (USD Million) 8.Competitive Landscape 8.1.Expansion and Acquisition Analysis 8.1.1.Expansion 8.1.2.Acquisitions 8.2.Partnerships/Collaborations/Agreements/Exhibitions 9.Company Profiles 9.1.Allergan Plc 9.1.1.Company Overview 9.1.2.Financial Performance 9.1.3.Product Benchmarking 9.1.4.Recent Development 9.2.Merz Pharma GmbH & Co. 9.2.1.Company Overview 9.2.2.Financial Performance 9.2.3.Product Benchmarking 9.2.4.Recent Development 9.3.Abbott Laboratories 9.3.1.Company Overview 9.3.2.Financial Performance 9.3.3.Product Benchmarking 9.3.4.Recent Development 9.4.Trigemina Inc. 9.4.1.Company Overview 9.4.2.Financial Performance 9.4.3.Product Benchmarking 9.4.4.Recent Development 9.5.Pfizer Inc. 9.5.1.Company Overview - 10 -

  11. Neuralgia Treatment Market Size Worth $2.83 Billion By 2027 9.5.2.Financial Performance 9.5.3.Product Benchmarking 9.5.4.Recent Development 9.6.Novartis 9.6.1.Company Overview 9.6.2.Financial Performance 9.6.3.Product Benchmarking 9.6.4.Recent Development 9.7.GlaxoSmithKline Plc. 9.7.1.Company Overview 9.7.2.Financial Performance 9.7.3.Product Benchmarking 9.7.4.Recent Development 9.8.Lupin 9.8.1.Company Overview 9.8.2.Financial Performance 9.8.3.Product Benchmarking 9.8.4.Recent Development 9.9.Cadila Healthcare Limited 9.9.1.Company Overview 9.9.2.Financial Performance 9.9.3.Product Benchmarking 9.9.4.Recent Development 9.10. Lundbeck Pharmaceuticals LLC 9.10.1.Company Overview 9.10.2.Financial Performance 9.10.3.Product Benchmarking 9.10.4.Recent Development 9.11. Biogen 9.11.1.Company Overview 9.11.2.Financial Performance 9.11.3.Product Benchmarking 9.11.4.Recent Development Access Press Release on Neuralgia Treatment Market: https://www.polarismarketresearch.com/press-releases/neuralgia-treatment-market About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present - 11 -

  12. Neuralgia Treatment Market Size Worth $2.83 Billion By 2027 around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com - 12 -

More Related